This is a Validated Antibody Database (VAD) review about human IFNAR2, based on 8 published articles (read how Labome selects the articles), using IFNAR2 antibody in all methods. It is aimed to help Labome visitors find the most suited IFNAR2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IFNAR2 synonym: IFN-R; IFN-alpha-REC; IFNABR; IFNARB; IMD45

Invitrogen
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; human; ; loading ...; fig 4b
Invitrogen IFNAR2 antibody (PBL, 21385-1) was used in blocking or activating experiments on human samples at (fig 4b). EMBO J (2018) ncbi
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; human; fig s1c
Invitrogen IFNAR2 antibody (pbl assay science, 21385-1) was used in blocking or activating experiments on human samples (fig s1c). Cell (2018) ncbi
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; human; loading ...; fig 4e
In order to identify factors that contribute to adenoviral transduction stimulation of IL-33 in endothelial cells, Invitrogen IFNAR2 antibody (Thermo Fisher Scientific, MMHAR-2) was used in blocking or activating experiments on human samples (fig 4e). J Immunol (2017) ncbi
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; mouse; loading ...; fig 3e-g
In order to study the restoration of immune function in chronic HIV infection, Invitrogen IFNAR2 antibody (eBioscience, MMHAR-2) was used in blocking or activating experiments on mouse samples (fig 3e-g). J Clin Invest (2017) ncbi
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; human; 1:1000; loading ...; fig 8b
In order to assess the effect of the IFN response on human noroviruses, Invitrogen IFNAR2 antibody (PBL Assay Science, 21385-1) was used in blocking or activating experiments on human samples at 1:1000 (fig 8b). J Virol (2016) ncbi
mouse monoclonal (MMHAR-2)
  • blocking or activating experiments; human
In order to characterize the role of PD-L1/PD-1 pathway in HIV-1 infection due to immune suppression by neutrophils, Invitrogen IFNAR2 antibody (Invitrogen, MMHAR-2) was used in blocking or activating experiments on human samples . PLoS Pathog (2014) ncbi
Miltenyi Biotec
human monoclonal (REA124)
  • flow cytometry; human; loading ...; fig s3
Miltenyi Biotec IFNAR2 antibody (Miltenyi Biotec, 130-099-556) was used in flow cytometry on human samples (fig s3). Eur J Immunol (2016) ncbi
R&D Systems
domestic sheep polyclonal
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 2d
  • western blot; rat; 1:1000; loading ...; fig 2b
R&D Systems IFNAR2 antibody (Affinity Biosciences, AF7014) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 2d) and in western blot on rat samples at 1:1000 (fig 2b). Front Cell Neurosci (2019) ncbi
Articles Reviewed
  1. Zeng S, Bai J, Jiang H, Zhu J, Fu C, He M, et al. Treatment With Liraglutide Exerts Neuroprotection After Hypoxic-Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway. Front Cell Neurosci. 2019;13:585 pubmed publisher
  2. Wu Y, Zhao W, Liu Y, Tan X, Li X, Zou Q, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. EMBO J. 2018;37: pubmed publisher
  3. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  4. Stav Noraas T, Edelmann R, Poulsen L, Sundnes O, Phung D, Küchler A, et al. Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery. J Immunol. 2017;198:3318-3325 pubmed publisher
  5. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  6. Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649 pubmed publisher
  7. Qu L, Murakami K, Broughman J, Lay M, Guix S, Tenge V, et al. Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol. 2016;90:8906-23 pubmed publisher
  8. Bowers N, Helton E, Huijbregts R, Goepfert P, Heath S, Hel Z. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog. 2014;10:e1003993 pubmed publisher